Ventilator-associated Pneumonia
Diagnosis
Fagon J, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 2000;132:621-30. Randomized study found use of BAL or PSB to dictate antibiotic treatment in suspected VAP resulted in lower mortality at 14 days and less antibiotic use compared to standard approach of clinical impression coupled with endotracheal aspirates. Initiation of antibiotic treatment for VAP was withheld until after obtaining specimens and antibiotics were stopped if cultures were negative.
PMID: 10766680
Free Full Text
Chastre J, Fagon J, Bornet-Lesco M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 152:231-240. Study compared immediate post-mortem BAL and PSB to lung biopsy histology and culture and found bronchoscopic specimens had a sensitivity of 82-91% and specificity of 78-89% compared to the gold standard of lung biopsy cultures, provided patients had no recent antibiotic changes prior to death and had not developed pneumonia prior to the terminal phase of their disease. Pertinent in that the above study by Fagon et al is predicated on the belief that BAL and PSB accurately diagnose VAP.
PMID: 7599829
Kirtland SH, Corley DE, Winterbauer RH, et al. The diagnosis of VAP: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997;112:445-57. Study with a similar design to the Chastre study but without restrictions on use of antibiotics or recent pneumonia. Authors found poor correlation between histologic findings and quantitative cultures from bronch specimens. Tracheal aspirates were 87% sensitive but 31% specific compared to biopsy culture. A sterile BAL had a PPV of 91% for sterile lung parenchyma.
PMID: 9266883
Free Full Text
Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006; 355:2619-30.Randomized trial (N= 740) found the use of bronchoalveolar-lavage with quantitative culture vs. routine culture of endotracheal-aspiration resulted in similar clinical outcomes and antibiotic use when used for the diagnosis of ventilator-associated pneumonia. The exclusion of immunocompromised patients and those infected or colonized with MRSA or Pseudomonas, the format for empiric antibiotic use, and the criterion for a positive BAL culture are concerns raised about the applicability of the findings.
PMID: 17182987
Free Full Text
Prevention and treatment
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia: Official statement of ATS and IDSA 2004. Am J Respir Crit Care Med 2005; 171:388-416. This in-depth evidence-based guideline on the management of nosocomial pneumonia emphasizes early collection of lower respiratory tract samples, early institution of antibiotics, a shorter duration of antibiotics for uncomplicated pneumonia, and use of linezolid, colistin, inhaled antibiotics, and combination therapy.
PMID: 15699079
Free Full Text
Chastre J, Wolff M, Fagon J et al. Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA 2003;290:2588-98. RCT comparing 8 vs. 15 days of antibiotic in 401 immunocompetent patients with VAP (diagnosed by bronchoscopic quantitative cultures) found no difference in pulmonary infection recurrence, 28-day mortality, ventilator free-days, organ failure-free days, and length of ICU stay between groups. The 8-day group had a higher recurrence of pulmonary infections due to non-lactose fermenting gram negative rods, including Pseudomonas aeruginosa (41% vs. 25%). This article constitutes the main evidence supporting shorter duration of VAP treatment in the above IDSA/ATS guidelines.
PMID: 14625336
Free Full Text
Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999;354:1851-8. Study found supine position is an independent risk factor for VAP and positioning at 45 reduces the risk, especially if patient receiving tube feeds.
PMID: 10584721
Free Full Text
De Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360:20-31. Previous smaller, single-center studies found selective digestive tract decontamination (SDD) improves ICU survival, but concern for antibiotic resistance and the generalizability of previous studies have kept this approach from gaining widespread acceptance. This large (5,939 patients) multicenter Dutch study found SDD and selective oropharyngeal decontamination (SOD) reduced mortality by about 3% after logistic regression. There was no emergence of resistant organisms, but the duration of monitoring was limited to the 6 months of the study.
PMID: 19118302
Free Full Text
Terragni PP, Antonelli M, Fumagalli R, et al. Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA 2010;303:1483-9. This trial of over 400 patients found a statistically non-significant reduction in VAP with early bedside tracheotomy (within 6-8 days of intubation) compared to late tracheostomy (13-15 days of intubation) (14% vs. 21%, p = 0.07). The early tracheotomy group had greater ventilator-free and ICU-free days but there was no difference in mortality or hospital length of stay. Only 69% assigned to the early group and 57% to the late group actually underwent tracheostomy, highlighting the difficulty of predicting the need for tracheostomy early in the course of illness.
PMID: 20407057
Free Full Text
